专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

11. 发明授权

US06419955B1 Process for making bisphosphonate compositions 有权
标题翻译：制备二膦酸盐组合物的方法
公开(公告)号：US06419955B1
公开(公告)日：2002-07-16
申请号：US09413989
申请日：1999-10-07
申请人： Rolf-Dieter Gabel , Jörn Möckel , Heinrich Woog
发明人： Rolf-Dieter Gabel , Jörn Möckel , Heinrich Woog
IPC分类号： A61K946
CPC分类号： A61K31/663 , A61K9/2013 , A61K9/4858
摘要： The present invention relates to a process for the preparation of bisphonate-containing pharmaceutical compositions for oral administration wherein the active substance is wet-granulated in a fluidized-bed granulator and the wet granulate is dried in the fluidised bed granulator. The dried granulate is further processed to produce desired dosage forms.
摘要翻译：本发明涉及一种制备用于口服给药的含双酚C的药物组合物的方法，其中将活性物质在流化床造粒机中湿法制粒，并将湿颗粒在流化床造粒机中干燥。将干燥的颗粒进一步处理以产生所需的剂型。

12. 发明授权

US06379706B2 Rapidly disintegrating coated pellets with delayed release 有权
标题翻译：快速崩解包衣颗粒缓释
公开(公告)号：US06379706B2
公开(公告)日：2002-04-30
申请号：US09773017
申请日：2001-01-31
申请人： Michaela Opitz , Hendrik Von Burën , Rolf-Dieter Gabel , Geoffrey Lee
发明人： Michaela Opitz , Hendrik Von Burën , Rolf-Dieter Gabel , Geoffrey Lee
IPC分类号： A61K916
CPC分类号： A61K9/1652 , A61K9/1617 , A61K9/1641 , A61K9/1694 , B01J2/20
摘要： The invention concerns pharmaceutical forms of administration that are in the form of pellets which contain a retarding agent in which the release rate of the active substance is not delayed or is substantially identical compared to corresponding pellets that contain no retarding agent. The release rate of these rapidly disintegrating pellets is at least about 90% within a time period of 30 minutes. In addition the present invention also concerns processes for the production these pellets.
摘要翻译：本发明涉及丸剂形式的药物形式，其含有阻滞剂，其中活性物质的释放速率不延迟或与不含阻滞剂的相应颗粒相比基本相同。这些快速崩解颗粒的释放速率在30分钟的时间段内为至少约90％。此外，本发明还涉及生产这些颗粒的方法。

13. 发明授权

US06224909B1 Fast decomposing pellets 有权
标题翻译：快速分解颗粒
公开(公告)号：US06224909B1
公开(公告)日：2001-05-01
申请号：US09147817
申请日：1999-05-11
申请人： Michaela Opitz , Hendrik Von Büren , Rolf-Dieter Gabel , Geoffrey Lee
发明人： Michaela Opitz , Hendrik Von Büren , Rolf-Dieter Gabel , Geoffrey Lee
IPC分类号： A61K914
CPC分类号： A61K9/1652 , A61K9/1617 , A61K9/1641 , A61K9/1694 , B01J2/20
摘要： The invention concerns pharmaceutical forms of administration that are in the form of pellets which contain a retarding agent in which the release rate of the active substance is not delayed or is substantially identical compared to corresponding pellets that contain no retarding agent. The release rate of these rapidly disintegrating pellets is at least about 90% within a time period of 30 minutes. In addition the present invention also concerns processes for the production these pellets.
摘要翻译：本发明涉及丸剂形式的药物形式，其含有阻滞剂，其中活性物质的释放速率不延迟或与不含阻滞剂的相应颗粒相比基本相同。这些快速崩解颗粒的释放速率在30分钟的时间段内为至少约90％。此外，本发明还涉及生产这些颗粒的方法。

14. 发明授权

US6143326A Oral pharmaceutical preparation containing ibandronat 有权
标题翻译：含有伊班膦酸钠的口服药物制剂
公开(公告)号：US6143326A
公开(公告)日：2000-11-07
申请号：US147149
申请日：1998-11-25
申请人： Jorn Mockel , Rolf-Dieter Gabel , Heinrich Woog
发明人： Jorn Mockel , Rolf-Dieter Gabel , Heinrich Woog
IPC分类号： A61K9/36 , A61K20060101 , A61K9/14 , A61K9/20 , A61K9/22 , A61K9/28 , A61K9/30 , A61K9/50 , A61K9/52 , A61K9/54 , A61K31/00 , A61K31/66 , A61K31/662 , A61K31/663 , A61K47/30 , A61K47/32 , A61K47/36 , A61K47/38 , A61K47/44 , A61P3/00 , A61P3/14 , A61P19/00 , A61P19/08 , A61P19/10 , A61P35/04 , C07F9/38
CPC分类号： A61K31/663 , A61K31/66 , A61K9/2846 , A61K9/2866
摘要： The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.
摘要翻译： PCT No.PCT / EP97 / 01940 Sec。 371日期：1998年11月25日 102（e）日期1998年11月25日PCT 1997年4月21日PCT PCT。出版物WO97 / 39755 日期1997年10月30日本发明涉及用于口服应用的耐受良好的药物组合物，其含有伊班膦酸盐或其生理上可耐受的盐作为活性物质，所述给药形式由含有活性物质的内部部分组成，不含活性物质的快速释放的活性物质。

15. 发明授权

US5955106A Pharmaceutical preparation containing metformin and a process for producing it 无效
标题翻译：含二甲双胍的药物制剂及其制备方法
公开(公告)号：US5955106A
公开(公告)日：1999-09-21
申请号：US793753
申请日：1997-03-14
申请人： Jorn Moeckel , Rolf-Dieter Gabel , Heinrich Woog
发明人： Jorn Moeckel , Rolf-Dieter Gabel , Heinrich Woog
IPC分类号： A61K9/20 , A61K9/28 , A61K9/48 , A61K31/155 , A61K47/30 , A61K47/36 , A61P3/08 , A61P3/10
CPC分类号： A61K9/2027 , A61K31/155 , A61K9/2054 , A61K9/2866
摘要： The present invention concerns pharmaceutical compositions containing metformin as an active substance and a hydrocolloid-forming agent as a retardant and optionally standard pharmaceutical auxiliary substances, the residual moisture content in the pharmaceutical composition being 0.5-3% by weight. The invention also concerns a process for producing pharmaceutical compositions containing metformin as an active substance and a hydrocolloid-forming agent as a retardant and optionally standard pharmaceutical auxiliary substances characterized in that the active substance and retarding agent or a portion thereof are granulated with an aqueous solvent which can optionally contain a binder and where appropriate the other portion of the retardant or other standard pharmaceutical auxiliaries are admixed with the granulate which is then dried until the residual moisture content is reduced to 0.5-3% by weight.
摘要翻译： PCT No.PCT / EP95 / 03610 Sec。 371日期1997年3月14日 102（e）1997年3月14日PCT PCT 1995年9月14日PCT公布。出版物WO96 / 08243 日期1996年3月21日本发明涉及含有作为活性物质的二甲双胍和作为阻滞剂和任选的标准药物辅助物质的水解胶体形成剂的药物组合物，药物组合物中的残留水分含量为0.5-3重量％。本发明还涉及一种生产含有作为活性物质的二甲双胍和作为阻滞剂的水胶体形成剂和任选的标准药物辅助物质的药物组合物的方法，其特征在于将活性物质和延缓剂或其一部分用水性溶剂其可任选地含有粘合剂，并且适当时将阻燃剂或其它标准药用助剂的其它部分与颗粒混合，然后将其干燥直到残余水分含量降低至0.5-3重量％。

16. 发明申请

US20110024419A1 TRANSFER CONTAINER FOR PHARMACEUTICAL RECIPIENTS 有权
标题翻译：转运用于药物接收的容器
公开(公告)号：US20110024419A1
公开(公告)日：2011-02-03
申请号：US12855491
申请日：2010-08-12
申请人： Rolf-Dieter Gabel , Martin Knierim
发明人： Rolf-Dieter Gabel , Martin Knierim
IPC分类号： B65D51/00
CPC分类号： A61M5/008 , A61L2/26 , A61L2202/182 , A61L2202/21 , A61M5/001 , A61M2207/00 , B65B3/003 , B65B55/027 , Y10S220/20 , Y10S604/905 , Y10T137/6851 , Y10T137/86292
摘要： A reusable container for the sterile transfer of pharmaceutical recipients, in particular of syringe bodies. The container comprises an outer case and a sterilizable interior, wherein the interior is microbially isolated from the environment of the container. The interior has at least one holder for accommodating at least one nest for storing a plurality of pharmaceutical recipients. The nest can be removably accommodated in the holder. The container further has at least one container door for removing or introducing the nest into the interior and at least one lock for coupling the container to a sterile space. The lock is configured in such a way that, after coupling to the sterile space, it is possible to open the container door without substantially suspending sterility.
摘要翻译：用于药物接收者，特别是注射器体的无菌转移的可重复使用的容器。容器包括外壳和可灭菌的内部，其中内部与容器的环境微生物隔离。内部具有至少一个保持器，用于容纳至少一个用于存储多个药物接收者的巢。巢可以可拆卸地容纳在支架中。容器还具有至少一个用于将嵌套移入或引入内部的容器门和用于将容器连接到无菌空间的至少一个锁。锁被配置成使得在联接到无菌空间之后，可以打开容器门而不会基本上悬挂无菌。

17. 发明申请

US20050089573A1 Oral pharmaceutical formulation containing ibandronate 审中-公开
标题翻译：含有伊班膦酸盐的口服药物制剂
公开(公告)号：US20050089573A1
公开(公告)日：2005-04-28
申请号：US10660785
申请日：2003-09-12
申请人： Joern Moeckel , Rolf-Dieter Gabel , Heinrich Woog
发明人： Joern Moeckel , Rolf-Dieter Gabel , Heinrich Woog
IPC分类号： A61K9/36 , A61K20060101 , A61K9/14 , A61K9/20 , A61K9/22 , A61K9/28 , A61K9/30 , A61K9/50 , A61K9/52 , A61K9/54 , A61K31/00 , A61K31/66 , A61K31/662 , A61K31/663 , A61K47/30 , A61K47/32 , A61K47/36 , A61K47/38 , A61K47/44 , A61P3/00 , A61P3/14 , A61P19/00 , A61P19/08 , A61P19/10 , A61P35/04 , C07F9/38 , A61K9/24
CPC分类号： A61K31/663 , A61K9/2846 , A61K9/2866 , A61K31/66
摘要： The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.
摘要翻译：本发明涉及用于口服应用的耐受良好的药物组合物，其含有伊班膦酸盐或其生理上可耐受的盐作为活性物质，所述给药形式由含有活性物质的内部部分组成，所述内部部分以不含活性物质的衣服包裹，发生活性物质的快速释放。

18. 发明授权

US06431399B1 Pharmaceutical dosing dispenser 有权
公开(公告)号：US06431399B1
公开(公告)日：2002-08-13
申请号：US09739040
申请日：2000-12-18
申请人： Rolf-Dieter Gabel , Jörn Möckel
发明人： Rolf-Dieter Gabel , Jörn Möckel
IPC分类号： B65G5900
摘要： A pill dispenser allows for alternating removal of two or more solid forms of pharmaceutical medications, such as tablets, film tablets, coated tablets, or capsules. The pill dispenser has a housing, a baseplate, at least two storage containers for receiving and storing a solid form of medication, and a dosing slide. The baseplate is attached to the bottom end of the housing and has at least one ejecting opening. The storage containers are adapted for receiving and storing solid forms of medications. Each storage container has a bottom opening. A dosing slide is movably mounted between the storage containers and the baseplate and has receiving openings arranged in the dosing slide so that each of the receiving openings can be positioned under a bottom opening of a storage container and above an ejecting opening.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式